S&P 500
(-0.02%) 5 221.42 points

Dow Jones
(-0.21%) 39 432 points

Nasdaq
(0.29%) 16 388 points

Oil
(1.20%) $79.20

Gas
(5.06%) $2.37

Gold
(-1.38%) $2 342.30

Silver
(-0.28%) $28.43

Platinum
(0.23%) $1 009.50

USD/EUR
(-0.18%) $0.927

USD/NOK
(-0.12%) $10.82

USD/GBP
(-0.27%) $0.796

USD/RUB
(-1.16%) $91.59

Realtime updates for Epizyme Inc [EPZM]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

Last Updated31 Dec 1970 @ 19:00

25% discount on Stockinvest.us - Use code: Podcast

0.00% $ 1.470

Live Chart Being Loaded With Signals

Commentary (31 Dec 1970 @ 19:00):

Epizyme, Inc., a commercial-stage biopharmaceutical company, discovers, develops, and commercializes novel epigenetic medicines for patients with cancer and other diseases in the United States...

Stats
Today's Volume	0.00
Average Volume	4.18M
Market Cap	0.00
EPS	$-0.210 ( 2022-08-09 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.704
ATR14	$0.0490 (3.33%)

Insider Trading

Date	Person	Action	Amount	type
2022-08-12	Giordano Michael F	Sell	8 994	Common Stock, par value $0.0001
2022-08-12	Goldfischer Carl	Sell	13 060	Common Stock, par value $0.0001
2022-08-12	Goldfischer Carl	Sell	8 994	Common Stock, par value $0.0001
2022-08-12	Goldfischer Carl	Sell	3 380 951	Common Stock, par value $0.0001
2022-08-12	Conroy Kevin T	Sell	53 324	Common Stock, par value $0.0001

INSIDER POWER
-89.17
Last 98 transactions
Buy: 31 679 726 \| Sell: 42 571 145

Volume Correlation

Long: 0.22 (neutral)

Short: -0.56 (weak negative)

Signal:(61.298) Neutral

Epizyme Inc Correlation

10 Most Positive Correlations
APOP	0.959
RMRM	0.951
MEIP	0.933
REAL	0.932
PCVX	0.93
NNOX	0.927
TYHT	0.925
CVGI	0.922
JFU	0.921
PRTA	0.921

10 Most Negative Correlations
XMTR	-0.948
ASTR	-0.938
INFI	-0.922
HRZN	-0.922
UPLD	-0.921
DTEA	-0.92
OM	-0.92
VNET	-0.916
LUNG	-0.914
IRWD	-0.913

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Epizyme Inc Correlation - Currency/Commodity

-0.66
( moderate negative )

-0.65
( moderate negative )

0.00
( neutral )

-0.27
( neutral )

0.65
( weak )

Epizyme Inc Financials

Annual	2021
Revenue:	$37.43M
Gross Profit:	$26.93M (71.95 %)
EPS:	$-2.45

FY	2021
Revenue:	$37.43M
Gross Profit:	$26.93M (71.95 %)
EPS:	$-2.45

FY	2020
Revenue:	$15.76M
Gross Profit:	$10.70M (67.85 %)
EPS:	$-2.29

FY	2019
Revenue:	$23.80M
Gross Profit:	$0.00 (0.00 %)
EPS:	$-1.930

Financial Reports:

No articles found.

Epizyme Inc

Epizyme, Inc., a commercial-stage biopharmaceutical company, discovers, develops, and commercializes novel epigenetic medicines for patients with cancer and other diseases in the United States. The company offers Tazemetostat for the treatment of metastatic or locally advanced epithelioid sarcoma for adults and pediatric patients. It also develops R-CHOP in front-line patients with high risk diffuse large B-cell lymphoma; and PARP inhibitor in patients with PARPi-resistant solid tumors, such as castration-resistant prostate cancer, small cell lung cancer, and others. In addition, the company develops Tazemetostat in patients with INI1-negative tumors in adults and pediatrics; PRMT5 inhibitor for patients with solid tumors; and PRMT1 inhibitor. It has collaboration agreements with Roche Molecular Systems, Inc.; Lymphoma Academic Research Organization; Eisai Co. Ltd.; HUTCHMED (China) Limited; and Roche Sequencing Solutions, Inc. The company was incorporated in 2007 and is headquartered in Cambridge, Massachusetts. As of August 11, 2022, Epizyme, Inc. operates as a subsidiary of Ipsen Biopharmaceuticals, Inc..

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators

Investing in the stock market involves risk and the value of your investment can fluctuate. The stock market can be affected by a variety of factors, including economic conditions, company performance, and global events. There is no guarantee of profit and you could lose money. Please consider your financial situation, investment goals, and level of risk tolerance before making any investment decisions. Consult with a financial advisor for personalized advice.